{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:10:29Z","timestamp":1779905429553,"version":"3.53.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monoclonal gammopathy of undetermined significance (MGUS) is the asymptomatic precursor of multiple myeloma (MM) and related disorders. Understanding the causes of MGUS is key to elucidating the causes of these malignancies. The association of MGUS and diet, including dietary patterns, remains unclear. We therefore assessed the relationship between diet and MGUS in the iStopMM a nationwide screening study for MGUS in Iceland where 75,422 individuals have been screened for MGUS. A food-frequency questionnaire was distributed to participants with 27,217 respondents, of whom 1,020 had MGUS at screening. Exposure was defined as dietary intake of specific dietary items and adherence to five dietary patterns identified through principal component analysis. Logistic regression was used to calculate odds ratios (OR) of having MGUS, adjusting for age, sex, physical activity, and education. No dietary patterns nor specific dietary components were associated with risk of MGUS overall. However, high consumption of dairy products was associated with increased odds (OR 2.01, 95% CI 1.16-3.65) of IgA MGUS, even after adjusting for multiple comparisons. These findings suggest that dietary habits are not a major risk factor for MGUS overall and therefore unlikely to be a major causative factor in the development of MM.<\/jats:p>","DOI":"10.1038\/s41408-026-01480-4","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:05:15Z","timestamp":1775671515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4434-9159","authenticated-orcid":false,"given":"Styrmir","family":"Hallsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingibjorg","family":"Gunnarsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Thordardottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-3530","authenticated-orcid":false,"given":"Sigrun","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E.","family":"Torfadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isleifur","family":"Olafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9201-1166","authenticated-orcid":false,"given":"Jon Thorir","family":"Oskarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri","family":"Olafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur J.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-7476","authenticated-orcid":false,"given":"Sigur\u00f0ur Yngvi","family":"Kristinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-8414","authenticated-orcid":false,"given":"S\u00e6mundur","family":"R\u00f6gnvaldsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"1480_CR1","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137.","journal-title":"Blood"},{"key":"1480_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121\u20137.","journal-title":"Leukemia"},{"key":"1480_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood-2022-163169","volume":"140","author":"TJ Love","year":"2022","unstructured":"Love TJ, R\u00f6gnvaldsson S, Thorsteinsdottir S, Aspelund T, Reed ER, Vidarsson B, et al. Prevalence of MGUS is high in the istopmm study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do. Blood. 2022;140:256\u20138.","journal-title":"Blood"},{"key":"1480_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, et al. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241\u20139.","journal-title":"N Engl J Med"},{"key":"1480_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362\u20139.","journal-title":"N Engl J Med"},{"key":"1480_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-021-04400-7","volume":"100","author":"MA Castaneda-Avila","year":"2021","unstructured":"Castaneda-Avila MA, Ulbricht CM, Epstein MM. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review. Ann Hematol. 2021;100:855\u201363.","journal-title":"Ann Hematol"},{"key":"1480_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","volume":"114","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood. 2009;114:791\u20135.","journal-title":"Blood"},{"key":"1480_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc. 2010;85:933\u201342.","journal-title":"Mayo Clin Proc"},{"key":"1480_CR9","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","volume":"1","author":"M Thordardottir","year":"2017","unstructured":"Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Korde N, et al. Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv. 2017;1:2186\u201392.","journal-title":"Blood Adv"},{"key":"1480_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","volume":"116","author":"O Landgren","year":"2010","unstructured":"Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood. 2010;116:1056\u20139.","journal-title":"Blood"},{"key":"1480_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","volume":"28","author":"O Landgren","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, et al. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014;28:1537\u201342.","journal-title":"Leukemia"},{"key":"1480_CR12","first-page":"117","volume":"12","author":"LM Brown","year":"2001","unstructured":"Brown LM, Gridley G, Pottern LM, Baris D, Swanso CA, Silverman DT, et al. Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control. 2001;12:117\u201325.","journal-title":"Cancer Causes Control"},{"key":"1480_CR13","first-page":"1065","volume":"18","author":"HD Hosgood 3rd","year":"2007","unstructured":"Hosgood HD 3rd, Baris D, Zahm SH, Zheng T, Cross AJ. Diet and risk of multiple myeloma in Connecticut women. Cancer Causes Control. 2007;18:1065\u201376.","journal-title":"Cancer Causes Control"},{"key":"1480_CR14","first-page":"79","volume":"50","author":"HD Vlajinac","year":"2003","unstructured":"Vlajinac HD, Pekmezovi\u0107 TD, Adanja BJ, Marinkovi\u0107 JM, Kanazir MS, Suvajdzi\u0107 ND, et al. Case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma. 2003;50:79\u201383.","journal-title":"Neoplasma"},{"key":"1480_CR15","doi-asserted-by":"publisher","first-page":"378s","DOI":"10.3945\/ajcn.113.071266","volume":"100","author":"TJ Key","year":"2014","unstructured":"Key TJ, Appleby PN, Crowe FL, Bradbury KE, Schmidt JA, Travis RC. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014;100:378s\u201385s.","journal-title":"Am J Clin Nutr"},{"key":"1480_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41375-023-02132-3","volume":"38","author":"F Castro","year":"2024","unstructured":"Castro F, Parikh R, Eustaquio JC, Derkach A, Joseph JM, Lesokhin AM, et al. Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study. Leukemia. 2024;38:438\u201341.","journal-title":"Leukemia"},{"key":"1480_CR17","doi-asserted-by":"publisher","first-page":"pkz025","DOI":"10.1093\/jncics\/pkz025","volume":"3","author":"DH Lee","year":"2019","unstructured":"Lee DH, Fung TT, Tabung FK, Colditz GA, Ghobrial IM, Rosner BA, et al. Dietary pattern and risk of multiple myeloma in two large prospective US cohort studies. JNCI Cancer Spectr. 2019;3:pkz025.","journal-title":"JNCI Cancer Spectr"},{"key":"1480_CR18","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/ijc.32928","volume":"147","author":"DH Lee","year":"2020","unstructured":"Lee DH, Fung TT, Tabung FK, Marinac CR, Devore EE, Rosner BA, et al. Prediagnosis dietary pattern and survival in patients with multiple myeloma. Int J Cancer. 2020;147:1823\u201330.","journal-title":"Int J Cancer"},{"key":"1480_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/bloodadvances.2023011608","volume":"8","author":"JM Joseph","year":"2024","unstructured":"Joseph JM, Hillengass J, Tang L, Lesokhin AM, Landgren O, Usmani SZ, et al. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. Blood Adv. 2024;8:538\u201348.","journal-title":"Blood Adv"},{"key":"1480_CR20","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00277-019-03825-5","volume":"98","author":"B Schmidt","year":"2019","unstructured":"Schmidt B, Debold E, Frank M, Arendt M, Dragano N, D\u00fcrig J, et al. Socioeconomic position is positively associated with monoclonal gammopathy of undetermined significance in a population-based cohort study. Ann Hematol. 2019;98:2761\u20137.","journal-title":"Ann Hematol"},{"key":"1480_CR21","doi-asserted-by":"publisher","first-page":"e0206047","DOI":"10.1371\/journal.pone.0206047","volume":"13","author":"M Thordardottir","year":"2018","unstructured":"Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Steingrimsdottir L, et al. Dietary intake is associated with risk of multiple myeloma and its precursor disease. PLoS ONE. 2018;13:e0206047.","journal-title":"PLoS ONE"},{"key":"1480_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol. 2003;30:110\u20135.","journal-title":"Semin Oncol"},{"key":"1480_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13578-019-0288-9","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, Hao GL, Wang BY, Gao CC, Wang YX, Li LS, et al. Function and dysfunction of plasma cells in intestine. Cell Biosci. 2019;9:26.","journal-title":"Cell Biosci"},{"key":"1480_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00480-w","volume":"11","author":"S R\u00f6gnvaldsson","year":"2021","unstructured":"R\u00f6gnvaldsson S, Love TJ, Thorsteinsdottir S, Reed ER, \u00d3skarsson J\u00de, P\u00e9tursd\u00f3ttir \u00cd, et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 2021;11:94.","journal-title":"Blood Cancer J"},{"key":"1480_CR25","unstructured":"Andresdottir E, Birgisdottir BE, Torfadottir JE. Assessing the validity of the food frequency questionnaire used in the SAGA cohort study with a special focus on fish consumption. University of Iceland; 2023."},{"key":"1480_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0095798418771807","volume":"44","author":"MW Watkins","year":"2018","unstructured":"Watkins MW. Exploratory factor analysis: a guide to best practice. J Black Psychol. 2018;44:219\u201346.","journal-title":"J Black Psychol"},{"key":"1480_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1753-4887.2004.tb00040.x","volume":"62","author":"PK Newby","year":"2004","unstructured":"Newby PK, Tucker KL. Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev. 2004;62:177\u2013203.","journal-title":"Nutr Rev"},{"key":"1480_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02289233","volume":"23","author":"HF Kaiser","year":"1958","unstructured":"Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Psychometrika. 1958;23:187\u2013200.","journal-title":"Psychometrika"},{"key":"1480_CR29","doi-asserted-by":"publisher","first-page":"205031211882291","DOI":"10.1177\/2050312118822912","volume":"7","author":"MR Stavseth","year":"2019","unstructured":"Stavseth MR, Clausen T, R\u00f8islien J. How handling missing data may impact conclusions: a comparison of six different imputation methods for categorical questionnaire data. SAGE Open Med. 2019;7:2050312118822912.","journal-title":"SAGE Open Med"},{"key":"1480_CR30","unstructured":"Buuren SV. Flexible imputation of missing data. 2nd ed. New York: Chapman and Hall\/CRC; 2018."},{"key":"1480_CR31","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria; 2022."},{"key":"1480_CR32","doi-asserted-by":"crossref","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","DOI":"10.18637\/jss.v045.i03"},{"key":"1480_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318.","journal-title":"J Stat Softw"},{"key":"1480_CR34","unstructured":"Kassambara A, Mundt F. factoextra: Extract and visualize the results of multivariate data analyses_. R package version 1.0.7; 2020."},{"key":"1480_CR35","unstructured":"Kuhn M, Jackson S, Cimentada J. corrr: Correlations in R. 2022."},{"key":"1480_CR36","unstructured":"Raiche G, Magis D. nFactors: Parallel Analysis and Other Non Graphical Solutions to the Cattell Scree Test. 2022."},{"key":"1480_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/0013164404272507","volume":"65","author":"CA Bernaards","year":"2005","unstructured":"Bernaards CA, Jennrich RI. Gradient projection algorithms and software for arbitrary rotation criteria in factor analysis. Educ Psychol Meas. 2005;65:676\u201396.","journal-title":"Educ Psychol Meas"},{"key":"1480_CR38","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1182\/blood-2022-167423","volume":"140","author":"JM Joseph","year":"2022","unstructured":"Joseph JM, Tang L, Hillengass J, Moysich K, Landgren O, Usmani S, et al. Low intake of fruits and vegetables and high intake of processed meats and juices are associated with risk of MGUS in the National Health and Nutrition Examination Survey (NHANES) Database. Blood. 2022;140:12556\u20138.","journal-title":"Blood"},{"key":"1480_CR39","doi-asserted-by":"publisher","first-page":"m511","DOI":"10.1136\/bmj.m511","volume":"368","author":"TJ Key","year":"2020","unstructured":"Key TJ, Bradbury KE, Perez-Cornago A, Sinha R, Tsilidis KK, Tsugane S. Diet, nutrition, and cancer risk: what do we know and what is the way forward? BMJ. 2020;368:m511.","journal-title":"BMJ"},{"key":"1480_CR40","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/blood.V128.22.3257.3257","volume":"128","author":"M Thordardottir","year":"2016","unstructured":"Thordardottir M, Lindqvist EK, Lund SH, Costello R, Torfadottir JE, Birgisdottir BE, et al. Dietary pattern and risk of monoclonal gammopathy of undetermined significance: a population-based study. Blood. 2016;128:3257\u20133257.","journal-title":"Blood"},{"key":"1480_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.12688\/f1000research.10703.1","volume":"6","author":"A Naska","year":"2017","unstructured":"Naska A, Lagiou A, Lagiou P. Dietary assessment methods in epidemiological research: current state of the art and future prospects. F1000Res. 2017;6:926.","journal-title":"F1000Res"},{"key":"1480_CR42","doi-asserted-by":"crossref","unstructured":"Willett W. Nutritional epidemiology. Oxford University Press; 2012.","DOI":"10.1093\/acprof:oso\/9780199754038.001.0001"},{"key":"1480_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00666-w","volume":"12","author":"MA Malik","year":"2022","unstructured":"Malik MA, Sweeney NW, Jafri M, Derkach A, Chmielewski C, Adintori PA, et al. Nutrition perceptions, needs and practices among patients with plasma cell disorders. Blood Cancer J. 2022;12:70.","journal-title":"Blood Cancer J"},{"key":"1480_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng.3247","volume":"47","author":"DF Gudbjartsson","year":"2015","unstructured":"Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47:435\u201344.","journal-title":"Nat Genet"},{"key":"1480_CR45","unstructured":"Gunnarsd\u00f3ttir S, Gu\u00f0mannsd\u00f3ttir R, \u00deorgeirsd\u00f3ttir H, Torfad\u00f3ttir JE, Steingr\u00edmsd\u00f3ttir L, Tryggvad\u00f3ttir EA, et al. Hva\u00f0 bor\u00f0a \u00cdslendingar? K\u00f6nnun \u00e1 matar\u00e6\u00f0i \u00cdslendinga 2019\u20132021: Helstu ni\u00f0urst\u00f6\u00f0ur og samanbur\u00f0ur vi\u00f0 k\u00f6nnun fr\u00e1 2010\u20132011 [What do Icelanders eat? Icelandic Diet Survey 2019\u20132021: Main results and comparison with the 2010\u20132011 survey]. Reykjav\u00edk: Directorate of Health and Nutritional Research Unit, University of Iceland; 2022. https:\/\/maturinnokkar.hi.is\/wp-content\/uploads\/2022\/03\/Hvadbordaislendingar_vefur_endanlegt.pdf."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01480-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:05:08Z","timestamp":1779206708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01480-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01480-4","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ST: Honoraria for scientific talks from Takeda, Abbvie, GSK and the Binding Site and travel grants from GSK and Amgen. Advisory board for Sanofi SYK: Research funding from Amgen and Bristol Meyers Squibb; Independent Data Monitoring Committee for Jansen. SR: Honoraria for scientific talks from Johnson & Johnson and Siemens Healthineers. Other co-authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}